发明名称 |
Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt |
摘要 |
<p>The present invention relates to a pharmaceutical composition that has improved storage stability with respect to dissolution comprising at least 2% w/w disintegrant(s) and solifenacin or pharmaceutical acceptable salt thereof which is substantially free of crystalline form and is free of degradation impurities, characterized in that the composition is prepared by wet granulation.</p> |
申请公布号 |
EP2778167(A1) |
申请公布日期 |
2014.09.17 |
申请号 |
EP20130001214 |
申请日期 |
2013.03.11 |
申请人 |
ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI |
发明人 |
FERHAT, FARSI |
分类号 |
C07D453/02;A61K9/16;A61K31/439;A61K47/08;A61K47/30;A61K47/38 |
主分类号 |
C07D453/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|